CANC
Culbertson A N & Co’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $392K | Sell |
16,177
-4,865
| -23% | -$118K | 0.06% | 113 |
|
2025
Q1 | $533K | Sell |
21,042
-1,443
| -6% | -$36.6K | 0.09% | 109 |
|
2024
Q4 | $597K | Buy |
22,485
+700
| +3% | +$18.6K | 0.09% | 105 |
|
2024
Q3 | $630K | Sell |
21,785
-410
| -2% | -$11.9K | 0.1% | 103 |
|
2024
Q2 | $621K | Buy |
22,195
+360
| +2% | +$10.1K | 0.11% | 99 |
|
2024
Q1 | $606K | Buy |
21,835
+4,275
| +24% | +$119K | 0.1% | 102 |
|
2023
Q4 | $506K | Buy |
17,560
+5,705
| +48% | +$164K | 0.09% | 103 |
|
2023
Q3 | $393K | Buy |
11,855
+1,135
| +11% | +$37.6K | 0.08% | 106 |
|
2023
Q2 | $393K | Buy |
10,720
+1,600
| +18% | +$58.7K | 0.08% | 104 |
|
2023
Q1 | $372K | Buy |
9,120
+1,200
| +15% | +$49K | 0.08% | 105 |
|
2022
Q4 | $406K | Hold |
7,920
| – | – | 0.09% | 102 |
|
2022
Q3 | $346K | Buy |
7,920
+650
| +9% | +$28.4K | 0.08% | 104 |
|
2022
Q2 | $381K | Hold |
7,270
| – | – | 0.08% | 104 |
|
2022
Q1 | $376K | Hold |
7,270
| – | – | 0.07% | 105 |
|
2021
Q4 | $429K | Hold |
7,270
| – | – | 0.08% | 104 |
|
2021
Q3 | $312K | Buy |
+7,270
| New | +$312K | 0.06% | 104 |
|